Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Tata Motors Eyeing to Acquire Ford’s Factory in India 37 views
- Tesla Increases Vehicle Prices Once Again 35 views
- Expect Even More Unique Electric Cars Says Ferrari 35 views
- Google Backed ShareChat Raises $300 Million From its Recent Financing Round 34 views
- Tesla Suspends Hiring Further Set to Lay Off 10% of its Labor Force 34 views